A Trial to Explore the Potential Benefit of Safinamide on Cognitive Impairment Associated With Parkinson's Disease
Clinical trial NCT01211587 · COMPLETED
Trial details
- NCT number
- NCT01211587
- Sponsor
- Newron Pharmaceuticals SPA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2012-04-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.